BPC 157 Banned: Key Facts on the Latest FDA Decision The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Peptides Lack Reliable Safety Information, Watchdog Warns Compounded "semaglutide" is not FDA approved semaglutide.com Q&A: Should you trust trending peptide injections?